There's not enough data to say if the immune therapy is helping (he's on traditional low-dose chemo as well), but it seems promising. The company (Torigen.com) is focused on animal treatment for now, but sees applications for humans in the future.
> one of the most common ways to treat cancer is radiation therapy with x-rays ... You can use these highly energetic photons to kill off cancer cells. The difficulty really is ... killing the cancer cells without killing the patient - but the problem with using x-rays is that you can't shoot them at tumors inside the body without also burning some of the tissue on the way to the tumor and behind it... But you can use beams of other particles instead and this is where particle physics enters ... A beam of protons is far less likely to interact with tissue on short distances
And it is still part of the "kinder" set (protons are "kinder" than x-rays).
New Cancer Treatment With Proton Flashes Goes on Trial
Patients still suffer adverse reactions, and you will have margins of error, not to mention you do not have unlimited time to develop a treatment plan that is perfect. It's a time/efficacy trade off and the goal is to hit as much of the cancer as possible, while maintaining a SAFE dose of radiation, not a zero dose. What is a safe dose? Well, the more aggressive your cancer the higher that number gets too.
Some patients still receive high dose radiation while on proton treatment simply because their cancer is that aggressive, typically suffering the same grade 1-2 diarrhea and vomiting as any other form of radiation.
Proton treatment is far superior for most cancers, especially deeper cancers like colon and prostate.
It's a living example of how tragic a new treatment option is, unfortunately proton centers are expensive to build and take years. So many people are still passing away from treatable disease and having to endure high dose chemotherapy in other cases.
Flash therapy is the part is which just now entering clinical trials, where you treat the patient with ultra-high dose rates (so you deliver the same dose of radiation, but in maybe 90 ms instead of 90 seconds). There are indications that healthy cells are better at recovering from the ulra-high dose rate than tumor cells are, which means it would have a protective effect on healthy tissue, but the mechanism behind it is not known. The type of radiation is not specified, it can be protons, electrons, x-rays, etc.
So "proton flash therapy" is a Flash therapy that uses protons. Other clinical trials are using electrons instead, i.e. "electron flash therapy".
Disclaimer: I am not a doctor or medical physicist, I’m just fortunate enough to briefly use a machine intended for this purpose in separate nuclear physics studies. I believe BNCT has been done before with reactor sources of neutrons, but for some reason not as a standard treatment and there’s only one left in Taiwan for this purpose. The new development, afaik, is the ability to use accelerator neutron sources for this. Would love it if anybody knows more!
/knows nothing about physics
Particle beams for cancer therapy aren't new; shortly after the invention of the cyclotrone, EO Lawrence did this with neutrons in the late 1940s and proton beams were being used successfully in the 50's. She leaves out these details and only mentions trials from the 1990s.
These aren't "tiny wins". These are massive advancements in cancer treatment. And they're happening every decade or so, and added together is drastically changing outcomes.
This is one study.
"Cancer mortality decreased by 20.1% (95% uncertainty interval [UI], 18.2%-21.4%) between 1980 and 2014, from 240.2 (95% UI, 235.8-244.1) to 192.0 (95% UI, 188.6-197.7) deaths per 100 000 population."
Also if you think there’s no sense of urgency, you haven’t talked to anyone actually in the field. Do you really think oncologists (pediatric oncologists!) aren't eager to cure their patients?
I glean from many non-main stream sources (who are generally labeled quacks or naysayers, I have lost track of sources) :
- There have been almost no improvements in cancer treatments especially chemotherapy for _several_decades. Some sleight of hand involving some statistics and the fact that cancer can now be diagnosed in an at an earlier stage, means that the survival rate that is calculated by the survival of people Beyond 5 years of the first diagnosis, is higher.
- The primary approach to treating cancer (especially with chemotherapy and radiation) appears flawed. Cancer is a systemic disease so even if you destroy the tumor, you will have more of those propping up, because the body is already predisposed to creating them.
- It's a money making scam ( just like any other industry) that thrives in keeping a patient as sick as possible for as long as possible
-A lot of naive, but well intention people fall for the above three points mentioned.
Of course any attempt to even mention that people could be wrong would be retaliated with: you don't-care-for-people-dying response. Heroics generally trumps common sense
I really want to do whole-body clonal work. Our bodies and genes are machines, yet we still haven't put them to work. We're plastering over the breaks with crude tools that feel like modern day bloodletting. The blast radius in the transduction pathways is huge and imprecise.
I've written extensively about this topic on HN. Give me a minute and I'll dig up some references.
Edit:
https://news.ycombinator.com/item?id=35321368
In the case of the family member in question it sounds like one of these therapies are an option after CAR-T treatment currently. But it might be a preferable option in the future. I'm not sure if that is related to novelty and lack of data or something else.
> When blinatumomab was approved, Amgen announced that the price for the drug would be US$178,000 per year, which made it the most expensive cancer drug on the market. Merck's pembrolizumab was priced at US$150,000 per year when it launched (in September 2014).[14] At the time of initial approval, only about 1,000 patients in the US had an indication for blinatumomab.
I take it they prefer to pump chemotherapy poison ito patients for financial reasons?
At the time I took blinatumomab, I had already had unsuccessful treatments with two different chemo regimens. At the hospital system I was at, at least one failed chemo regimen was a pre-requisite for blinatumomab, as it was only indicated for "refractory" or "recurrent" cancers. I assume this is more related to the chance of acute death and (at the time) relative newness of blinatumomab compared to established chemotherapy regimens. (B-cell ALL is sadly very common in children, but this fortunately means that there is a LOT of funding research into the disease.)
After going through 3 one-month cycles of blinatumomab, it was becoming less effective, but I was able to line up a allogenic stem cell transplant which has (knock on a thousand woods) kept me clean for the 8 years since.
I almost don't want to even know... if I find out it costs only ~$5 to develop a dose, and they're charging $200k to dying people... ugh
I'd be curious to know if people who have endured famines, controlled for age, have lower (and/or higher) rates of some cancers in certain phases of their lives.
Of course looking at the effect of famine on an adult populations would do more to investigate your hypothesis than the effect on developing children.
But famine seems a bit extreme, no? Aren’t there also regional studies that show regional dietary/nutritional factors that correlate with lower cancer rates?
We opted for surgical removal instead.
Radiation therapy can target specific areas. It's still used instead of chemo in some cases.
Interesting and extremely cheap.
Seems scientist did find benefits as well in various trials, examples (more can be though with Googling, e.g. I know of a study of the effects on breast cancer in mice):
- https://pubmed.ncbi.nlm.nih.gov/30093705/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437363/
- https://baltimorepostexaminer.com/human-patients-are-given-f...
Not everyone has had success:
- https://karger.com/cro/article/14/2/886/820730/Drug-Induced-...